Previous 10 | Next 10 |
HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, kicks-off its annual series of events by hosting a scientific symposium at the Museum of Science, in Bos...
HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions, today announced an agreement to adopt BioVolume's leading 3D imaging and thermal technolo...
2023-07-24 18:34:09 ET Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Conference Call July 24, 2023, 04:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Officer Conference Call Participants Matt Hewitt...
2023-07-24 16:15:39 ET Champions Oncology press release ( NASDAQ: CSBR ): Q4 Non-GAAP EPS of -$0.17 misses by $0.02 . Revenue of $13.1M (+1.6% Y/Y) beats by $0.24M . For further details see: Champions Oncology Non-GAAP EPS of -$0.17 misses by $0.02, reven...
Record Annual Revenue of $53.9 Million HACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its ...
HACKENSACK, NJ / ACCESSWIRE / July 20, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the fourth quart...
HACKENSACK, NJ / ACCESSWIRE / April 17, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled research organization that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic (PPMO) integration, announced the launch of its therapeutic d...
HACKENSACK, NJ / ACCESSWIRE / April 5, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced that its Board of Directors has approved a share repur...
2023-03-17 15:52:06 ET Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matthew Hewitt - Craig-Hallum Presentation ...
2023-03-15 17:05:34 ET Champions Oncology press release ( NASDAQ: CSBR ): Q3 Non-GAAP EPS of -$0.16 misses by $0.15 . Revenue of $12.77M (-3.3% Y/Y) misses by $0.36M . For further details see: Champions Oncology Non-GAAP EPS of -$0.16 misses by $0.15, rev...
News, Short Squeeze, Breakout and More Instantly...
Champions Oncology Inc. Company Name:
CSBR Stock Symbol:
NASDAQ Market:
Champions Oncology Inc. Website:
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...